ArticleAnnals of medicine2025
Five years comparation of efficacy and safety after ICL-V4c implantation for high and super high myopia correction.
Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Evaluating Rotational Stability of the Visian V4b TICL in Patients with High Myopic Astigmatism.Ophthalmology and therapy · 2026Article
- Evaluation of retinochoroidal changes after implantable collamer lens implantation: insights from UWF-SS-OCTA and AI-based 3D modeling.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- Implantable collamer lens combined with femtosecond laser-assisted arcuate keratotomy and toric implantable collamer lens for high myopia with moderate-to-low astigmatism corrections: a comparative study.BMC ophthalmology · 2026Article
- Comparative Study of ICL V4c Decentration in Vertical vs Horizontal Implantation: Association with Angle Alpha and Validation of Equivalent Visual Quality.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Comparison of three-dimensional surgical system versus binocular microscope for implantable Collamer lens implantation: a randomized clinical trial.International journal of ophthalmology · 2026Article
- Characteristics of biological parameters and implantable collamer lens (ICL) size selection in moderate, high, and super-high myopia eyes.BMC ophthalmology · 2025Observational
- Visual related quality of life after ICL V4c implantation in high myopia patients: a mini review.Frontiers in medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe objective of the investigation is to examine the long term efficacy, safety, and predictability of ICL-V4c implantation for high and super-high myopic patients in order to provide reliable guidance for the selection of refractive surgical procedures.
methodsWe reviewed 125 eyes from 64 patients who implanted ICL-V4c at the Refractive Surgery Center of West China Hospital in Chengdu, China, between May 2015 and January 2017. These eyes were divided into two groups based on their preoperative spherical equivalent (SE) degree: high myopia (≥ -10D) and super-high myopia groups (< -10D). We followed up with the patients over 5 years and evaluated several parameters, including uncorrected visual acuity (UDVA), corrected visual acuity (CDVA), axial length (AL), refractive error, endothelial cell density (ECD), intraocular pressure (IOP), white-to-white distance (WTW), and vault.
resultsThe efficacy indices of ICL-V4c implantation in high and super-high myopia groups were 0.91 ± 0.23 and 0.80 ± 0.25, respectively at 5 years after operation. Compared to high myopia group, the efficacy index of super-high myopia was obviously decreased (
conclusionsICL-V4c implantation is effective, safe, and stable for correcting high and super-high myopia. However, ophthalmologists need to be aware of the potential for greater myopia regression in super-high myopic patients, as well as the increase in axial length and associated fundus complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.